Le Lézard
Classified in: Science and technology
Subject: Stock Sale/Buyback

Tufin Announces Upsizing and Pricing of Secondary Public Offering of Ordinary Shares


Tufin Software Technologies Ltd. (NYSE: TUFN) ("Tufin"), a company pioneering a policy-centric approach to security and IT operations, today announced that it has upsized and priced a secondary public offering of 4,279,882 ordinary shares at a public offering price of $17.00 per share. The offering was upsized from the previously announced 3,500,000 ordinary shares. The ordinary shares are being offered by certain selling shareholders pursuant to a registration statement on Form F-1 filed with the U.S. Securities and Exchange Commission (the "SEC"). In connection with the offering, certain selling shareholders have granted the underwriters a 30-day option to purchase up to an additional 641,982 ordinary shares at the public offering price less the underwriting discount. The offering is expected to close on December 9, 2019, subject to customary closing conditions. Tufin will not receive any proceeds from the sale of ordinary shares.

Tufin's ordinary shares are listed on the New York Stock Exchange under the ticker symbol "TUFN."

J.P. Morgan Securities LLC, Barclays Capital Inc. and Jefferies LLC are acting as book-running managers in the offering and as representatives of the underwriters. Oppenheimer & Co. Inc., Robert W. Baird & Co. Incorporated, Piper Jaffray & Co., Stifel, Nicolaus & Company, Incorporated, William Blair & Company, L.L.C., and D.A. Davidson & Co. are acting as co-managers in the offering.

The offering is being made only by means of a prospectus. When available, the final prospectus for the offering may be obtained from J.P. Morgan Securities LLC, c/o Broadridge Financial Solutions, 1155 Long Island Avenue, Edgewood, NY 11717, Telephone: 1-866-803-9204; or Barclays Capital Inc., c/o Broadridge Financial Solutions, 1155 Long Island Avenue, Edgewood, NY 11717, Telephone: 1-888-603-5847, or by email at Barclaysprospectus@broadridge.com; or Jefferies LLC, Attention: Equity Syndicate Prospectus Department, 520 Madison Avenue, 2nd Floor, New York, NY 10022, Telephone: 1-877-547-6340, or by email at Prospectus_Department@Jefferies.com.

A registration statement on Form F-1 related to these securities has been filed with, and declared effective by, the SEC. The registration statement can be accessed through the SEC's website at www.sec.gov. This press release shall not constitute an offer to sell or the solicitation of an offer to buy nor may there be any sale of these securities in any state or jurisdiction in which such an offer, solicitation or sale would be unlawful prior to registration or qualification under the securities laws of any such state or jurisdiction.

About Tufin

Tufin (NYSE: TUFN) simplifies management of some of the largest, most complex networks in the world, consisting of thousands of firewall and network devices and emerging hybrid cloud infrastructures. Enterprises select the company's Tufin Orchestration Suitetm to increase agility in the face of ever-changing business demands while maintaining a robust security posture. The Tufin Orchestration Suite reduces the attack surface and meets the need for greater visibility into secure and reliable application connectivity. With over 2,000 customers since its inception, Tufin's network security automation enables enterprises to implement changes in minutes instead of days, while improving their security posture and business agility.

Forward Looking Statements

This press release contains forward looking statements, including among other things, statements concerning the completion of the offering of ordinary shares, and other statements identified by words such as "could," "expects," "intends," "may," "plans," "potential," "should," "will," "would," or similar expressions and the negatives of those terms. Forward-looking statements are not promises or guarantees of future performance, and are subject to a variety of risks and uncertainties, many of which are beyond our control. Actual results could differ materially from those anticipated in such forward-looking statements as a result of various risks and uncertainties, which include, without limitation, market risks and uncertainties and the satisfaction of customary closing conditions for an offering of securities. These and other risks and uncertainties are described more fully in the preliminary prospectus, and in particular in the section captioned "Risk Factors", related to the public offering filed with the SEC. Forward-looking statements speak only as of the date hereof, and, except as required by law, Tufin undertakes no obligation to update or revise these forward-looking statements.


These press releases may also interest you

at 16:10
F5 Networks today introduced NGINX Controller 3.0, a cloud-native application delivery solution to help organizations increase business agility, mitigate risk, and enhance their customers' digital experiences. Built to unleash productivity and...

at 16:10
TESSCO TECHNOLOGIES INCORPORATED today reported financial results for its third quarter of fiscal 2020, ended December 29, 2019. Third-Quarter Highlights:         Third Quarter FY 2020   Third Quarter FY 2019  ...

at 16:10
NCR Corporation will release its fourth quarter and full year 2019 financial results after the market close on Tuesday, Feb. 11, 2020. A conference call is scheduled at 4:30 p.m. Eastern Time on the same day. Participants should plan to access the...

at 16:10
Jubilant Radiopharma, the Radiopharmaceutical Division of Jubilant Pharma Ltd, announced today that the company received approval from Health Canada for Drax Exametazine® (Kit for the Preparation of Tc99m Exametazime for leukocyte labeling)....

at 16:05
Alnylam Pharmaceuticals, Inc. , the leading RNAi therapeutics company, announced today that it will report financial results for the fourth quarter and year ending December 31, 2019 on Thursday, February 6, 2020, before the U.S. financial markets...

at 16:05
Concert Pharmaceuticals, Inc. today announced that it intends to offer and sell shares of its common stock in an underwritten registered public offering. All of the shares in the offering are to be sold by Concert. The offering is subject to market...



News published on 4 december 2019 at 21:10 and distributed by: